N@N

Market Maker Surveillance Report. DYN, GTY, ACFC, CMED, AFFY, PLX, Losing Stocks With Lowest Price Friction For Tuesday, Decem

December 6, 2011 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 3643 companies with "abnormal" market making, 2613 companies with positive Friction Factors and 3259 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Tuesday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. DYNEGY INC (NYSE:DYN), GETTY REALTY CORP (NYSE:GTY), ATLANTIC COAST FINANCIAL COR (NASDAQ:ACFC), CHINA MEDICAL TECH-SPON ADR (NASDAQ:CMED), AFFYMAX INC (NASDAQ:AFFY), PROTALIX BIOTHERAPEUTICS INC (AMEX:PLX). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     DYN        $-0.440      -13.97%      644,844         28.45%       979,808         43.23%       -334,964        -7,613  
     GTY        $-1.780      -11.95%      463,171         33.12%       509,573         36.44%       -46,402         -261    
     ACFC       $-0.390      -15.35%      32,870          41.47%       42,792          53.98%       -9,922          -254    
     CMED       $-0.810      -23.96%      3,833,256       47.77%       4,192,603       52.24%       -359,347        -4,436  
     AFFY       $-0.880      -14.06%      1,501,714       48.53%       1,578,408       51.01%       -76,694         -872    
     PLX        $-0.800      -12.92%      441,080         31.13%       448,146         31.63%       -7,066          -88     

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net dollar losses (Change) and extremely low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows DYN with a dollar loss Tuesday of $-0.44000 and a Friction Factor of -7,613 shares. That means that it only took 7,613 more shares of selling than buying to move DYN lower by one penny. This means the Market Makers are allowing the stock to drop quickly (low friction). The combination of low friction and negative market direction can drive prices lower faster than normal.

DYNEGY INC (NYSE:DYN) - Dynegy Inc., through its subsidiaries, engages in the production and sale of electric energy, capacity, and ancillary services in the United States. The company sells electric energy, capacity, and ancillary services on a wholesale basis from its natural gas-fired, coal-fired, and oil-fired power generation facilities. As of December 31, 2009, its power generation portfolio consisted of approximately 12,300 megawatts of baseload, intermediate, and peaking power plants fueled by a mix of natural gas, coal, and fuel oil. The companys customers include regional transmission organizations, independent system operators, integrated utilities, municipalities, electric cooperatives, transmission and distribution utilities, industrial customers, power marketers, other power generators, commercial end-users, and financial participants, such as banks and hedge funds. Dynegy Inc. was founded in 1985 and is based in Houston, Texas.

GETTY REALTY CORP (NYSE:GTY) - Getty Realty Corp. operates as a real estate investment trust (REIT) in the United States. The company engages in the ownership and leasing of retail motor fuel and convenience store properties, and petroleum distribution terminals. The companys properties are leased or sublet to distributors and retailers engaged in the sale of gasoline and various motor fuel products, convenience store products, and automotive repair services. As of December 31, 2006, the company owned 836 properties and leased 216 additional properties in 13 states located principally in the northeast United States. Getty Realty Corp. elected to qualify as a REIT. As a REIT, the company would not be subject to federal income tax, provided it distributes at least 90% of its REIT taxable income to its shareholders. The company was founded in 1955 and is headquartered in Jericho, New York.

ATLANTIC COAST FINANCIAL COR (NASDAQ:ACFC) - Atlantic Coast Federal Corporation operates as the bank holding company for Atlantic Coast Bank that provides various banking services to individual and business customers primarily in southern coastal Georgia and northern coastal Florida. Its deposit products include checking accounts, savings accounts, money market accounts, demand deposit accounts, time deposit accounts, and certificates of deposit. The companys loan portfolio comprises one- to four-family residential first and second mortgage loans, home-equity loans, commercial real estate loans, commercial and residential construction loans, land and multi-family real estate loans, commercial business loans, and automobile and other consumer loans. As of March 31, 2010, it operated through 12 locations. The company was founded in 1939 and is headquartered in Waycross, Georgia.

CHINA MEDICAL TECH-SPON ADR (NASDAQ:CMED) - China Medical Technologies, Inc., a medical device company, develops, manufactures, and markets advanced immunodiagnostic and molecular diagnostic products primarily in the Peoples Republic of China. The company offers IVD products, which utilize ECLIA technology, fluorescent in situ hybridization (FISH) technology, and surface plasmon resonance (SPR) technology to detect and monitor various diseases and disorders through the laboratory evaluation and analysis of blood, urine, or other body fluids. It offers ECLIA system, which includes ECLIA analyzer for detecting the minute levels of light triggered by combining reagents with body fluid samples to produce diagnostic results; and reagent kits for detecting and monitoring various types of diseases and disorders, including thyroid disorders, diabetes, hepatitis, SARS, Down syndrome, liver fibrosis, disorders related to reproduction and growth, and various types of tumors. The company also provides FISH imaging analysis system that enables medical practitioners to visualize and locate DNA sequences in human cells for identifying chromosomal abnormalities, using FISH technology; and offers FISH probes used for prenatal and cancer management. The FISH probes are used for the detection and monitoring the course of bladder cancer; treatment of breast cancer; prediction and diagnosis of cervical cancer; diagnosis and prognosis of various leukemias and multiple myeloma; detection of epidermal growth factor receptor abnormalities; detection of Trisomy 21, Trisomy 18, Trisomy 13, Turner syndrome, Trisomy X, XYY syndrome, DiGeorge syndrome, and triploidy; and diagnosis of prostate cancer. In addition, it offers HPV-DNA chips and SPR-based analysis system for the diagnosis of human papillomavirus (HPV) infection and genotyping of HPV. The company sells its products through distributors. China Medical Technologies, Inc. was founded in 1999 and is based in Beijing, the Peoples Republic of China.

AFFYMAX INC (NASDAQ:AFFY) - Affymax, Inc., a biopharmaceutical company, engages in the development of drugs for the treatment of serious and life-threatening conditions. The company is developing Hematide, which is in Phase III clinical trials for the treatment of anemia associated with chronic renal failure. Hematide is a synthetic peptide-based erythropoiesis stimulating agent designed to stimulate production of red blood cells. Affymax, Inc. has strategic alliance agreements with Takeda Pharmaceutical Company Limited and Nektar Therapeutics AL, Corporation to manufacture, develop, and commercialize Hematide. The company was founded in 2001 and is based in Palo Alto, California.

PROTALIX BIOTHERAPEUTICS INC (AMEX:PLX) - Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system primarily in the United States. The companys lead product candidate includes taliglucerase alfa, a proprietary plant cell expressed recombinant Glucocerebrosidase enzyme for the treatment of Gaucher disease, which has completed Phase III clinical trial. It also develops PRX-102, a proprietary alpha Galactosidase enzyme for the treatment of Fabry disease, a genetic lysosomal storage disorder in humans, the symptoms of which involve the accumulation of lipids in the cells of the kidneys, heart, and other organs; a proprietary plant cell-based acetylcholinesterase and its molecular variants for use in various therapeutic and prophylactic indications, including a Biodefense program; and an organophosphate-based pesticide treatment program. In addition, the companys product includes pr-antiTNF, a preliminary preclinical stage product for the treatment of various autoimmune diseases, such as rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing, spondylitis, psoriatic arthritis, and plaque psoriasis. It has strategic collaborations with Teva Pharmaceutical Industries, Ltd. for the development and manufacturing of two proteins using the companys ProCellEx protein expression system; and Yeda Research and Development Company Limited to design Glucocerebrosidase for the treatment of Gaucher disease, as well as has a collaborative research agreement with Icon Genetics AG to license Icons amplification technology for utilization in the expression of its products. The company was founded in 1993 and is based in Carmiel, Israel.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net